-
Mashup Score: 0
ATLANTA — IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease, a speaker reported.The results of the IVUS-DCB trial were presented at the American College of Cardiology Scientific Session.
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 11Managing the Challenges of Paying for Gene Therapies - ICER - 16 day(s) ago
This paper explains potential reforms to white bagging, brown bagging, and site of service policies. Learn more.
Source: icer.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
ATLANTA — IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease, a speaker reported.The results of the IVUS-DCB trial were presented at the American College of Cardiology Scientific Session.
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3Highlights From the Upcoming SCAI Annual Scientific Sessions - 17 day(s) ago
Structural Track Director George Hanzel, MD, FSCAI, describes hot topics in structural heart disease and plans for education at the Scientific Sessions.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
ATLANTA — IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease, a speaker reported.The results of the IVUS-DCB trial were presented at the American College of Cardiology Scientific Session.
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 16Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome - 17 day(s) ago
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology. “In light of emerging data on the CVD risk conferred by comorbidity risk factors, the American Heart Association introduced the framework for the cardiovascular-kidney-metabolic
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4FDA approves novel bioresorbable scaffold for treating chronic limb-threatening ischemia - 17 day(s) ago
Abbott announced the FDA has approved its novel below-the-knee, bioresorbable, drug-eluting scaffold for people with chronic limb-threatening ischemia. The approval is based on the results of the LIFE-BTK trial, presented at Transcatheter Cardiovascular Therapeutics 2023, which compared the scaffold (Esprit BTK everolimus-eluting resorbable scaffold system) with conventional balloon angioplasty
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 16Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome - 18 day(s) ago
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology. “In light of emerging data on the CVD risk conferred by comorbidity risk factors, the American Heart Association introduced the framework for the cardiovascular-kidney-metabolic
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4FDA approves novel bioresorbable scaffold for treating chronic limb-threatening ischemia - 18 day(s) ago
Abbott announced the FDA has approved its novel below-the-knee, bioresorbable, drug-eluting scaffold for people with chronic limb-threatening ischemia. The approval is based on the results of the LIFE-BTK trial, presented at Transcatheter Cardiovascular Therapeutics 2023, which compared the scaffold (Esprit BTK everolimus-eluting resorbable scaffold system) with conventional balloon angioplasty
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 16Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome - 18 day(s) ago
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology. “In light of emerging data on the CVD risk conferred by comorbidity risk factors, the American Heart Association introduced the framework for the cardiovascular-kidney-metabolic
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease @ACCintouch #Cardiotwitter Read more👇 https://t.co/uYSwalP2fX